National Planning Corporation’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-12,900
| Closed | -$42K | – | 647 |
|
|
2017
Q3 | $42K | Sell |
12,900
-45,333
| -78% | -$148K | ﹤0.01% | 676 |
|
|
2017
Q2 | $186K | Buy |
58,233
+6,000
| +11% | +$19.2K | 0.01% | 689 |
|
|
2017
Q1 | $153K | Hold |
52,233
| – | – | 0.01% | 664 |
|
|
2016
Q4 | $115K | Sell |
52,233
-5,000
| -9% | -$11K | 0.01% | 667 |
|
|
2016
Q3 | $93K | Sell |
57,233
-7,100
| -11% | -$11.5K | 0.01% | 633 |
|
|
2016
Q2 | $69K | Buy |
64,333
+100
| +0.2% | +$107 | 0.01% | 652 |
|
|
2016
Q1 | $61K | Sell |
64,233
-667
| -1% | -$633 | 0.01% | 629 |
|
|
2015
Q4 | $70K | Sell |
64,900
-15,800
| -20% | -$17K | 0.01% | 705 |
|
|
2015
Q3 | $114K | Sell |
80,700
-18,000
| -18% | -$25.4K | 0.01% | 596 |
|
|
2015
Q2 | $196K | Sell |
98,700
-9,000
| -8% | -$17.9K | 0.02% | 586 |
|
|
2015
Q1 | $248K | Sell |
107,700
-4,000
| -4% | -$9.21K | 0.02% | 535 |
|
|
2014
Q4 | $303K | Sell |
111,700
-500
| -0.4% | -$1.36K | 0.02% | 540 |
|
|
2014
Q3 | $227K | Sell |
112,200
-13,700
| -11% | -$27.7K | 0.02% | 632 |
|
|
2014
Q2 | $336K | Sell |
125,900
-14,950
| -11% | -$39.9K | 0.03% | 534 |
|
|
2014
Q1 | $514K | Sell |
140,850
-2,500
| -2% | -$9.12K | 0.04% | 367 |
|
|
2013
Q4 | $639K | Buy |
143,350
+2,500
| +2% | +$11.1K | 0.06% | 312 |
|
|
2013
Q3 | $614K | Buy |
140,850
+19,400
| +16% | +$84.6K | 0.06% | 306 |
|
|
2013
Q2 | $499K | Buy |
+121,450
| New | +$499K | 0.06% | 280 |
|